05:04 PM EDT, 07/21/2025 (MT Newswires) -- CASI Pharmaceuticals ( CASI ) said Monday it named David Cory as chief executive and member of the board.
Wei-Wu He will step down as CEO and will remain as executive chair of the board, the company said.
Cory was most recently CEO of LIB Therapeutics, CASI said.